Cysteinylation and homocysteinylation of plasma protein thiols during ageing of healthy human beings by Rossi, Ranieri et al.
Introduction
According to the ‘free radical hypothesis’, the ageing process is a
progressive accumulation of oxidative changes leading to disease
and death [1, 2]. Studies also show age-related declines in both
exogenous and endogenous antioxidant systems including vita-
mins C and E, glutathione (GSH) and antioxidant enzymes [3–6].
Intracellular thiols such as GSH are essential in maintaining the
highly reduced environment inside the cell, whereas extracellular
thiols also constitute an important component in antioxidant
defence. Because the response of a cell to oxidative stress typi-
cally involves alterations in thiol content, plasma thiol concentra-
tions are increasingly utilized for clinical and translational research
involving oxidative stress [7–13], and for routine clinical diagnosis
and monitoring of various human diseases and metabolic disor-
ders [14–17]. Human plasma contains homocysteine (HcySH),
cysteinylglycine (CysGlySH), cysteine (CysSH) and GSH as
reduced thiols. These thiols are also found as low-molecular-mass
(symmetrical) disulphides, i.e. homocystine ([HcyS]2), cystinil-
glycine ([CysGlyS]2), cystine ([CysS]2) and glutathione disulphide
(GSSG). The measurement of these thiols in human plasma is of
interest because most of them are metabolically related and dis-
turbances of their concentrations can correspond to disorders of
metabolism that occurs during ageing [18]. Ageing has recently
been correlated to a decrease in human plasma GSH and
CysGlySH and the concomitant increase in most oxidized forms of
thiols as well as to a parallel increase in total Cys and total Hcy,
probably due to an augmented efflux of these amino acids from
various organs [19].
In human plasma, concentration of protein sulphydryl groups
(PSHs) is in the 0.4–0.5 mM range, whereas that of low-
molecular-mass thiols is in the 0.1–20 M range [19, 20]. PSHs
are common targets of oxidative modifications [21–23]. They are
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present as reduced thiols and/or mixed disulphides with HcySH,
CysGlySH, CysSH and GSH (as a whole referred to as S-thiolated
proteins) [19, 24, 25], through a reaction of S-thiolation, in
which protein thiols form a mixed disulphide bond with low-
molecular-mass thiols. This process plays both a regulatory and
an antioxidant role, because it protects protein cysteinyl thiols
against irreversible oxidation (i.e. further oxidation to sulphinic
and sulphonic acids) [26] and also has a role in protein redox
regulation [27].
There exist reports on the level of GSH, GSSG, malondialde-
hyde, protein carbonyls, 4-hydroxy-2,3-trans-nonenal, uric acid
and the redox couples GSH/GSSG and CysSH/(CysS)2, as well as
on antioxidant enzyme activities (superoxide dismutases and GSH
peroxidases) in blood and plasma of healthy populations during
ageing [6, 19, 28–32]. In these studies, tendencies for some
parameters and also significant correlations were established,
showing an increase in pro-oxidative effects and a decrease in
antioxidative ones during ageing.
S-thiolated plasma proteins have been detected in healthy human
beings, but increase in patients with cardiovascular diseases and in
uremic patients on haemodialysis [33, 34]. Although increased pro-
tein S-thiolation is considered an in vivo marker of oxidative injury,
scarce attention has been paid to the significance and quantification
of S-thiolated proteins in blood plasma of healthy individuals during
ageing. The purpose of the present study was to determine the rela-
tive amount of S-thiolated proteins (i.e. homocysteinylated, cys-
teinylglycinylated, glutathionylated and cysteinylated proteins) to the
total protein thiols (i.e. the sum of protein sulphydryl groups and
protein mixed disulphides with HcySH, CysGlySH, CysSH and GSH)
in the plasma of healthy individuals aged 20 to 93 years. The results
indicate a significant age-dependent decrease in reduced plasma
PSHs, as well as an age-dependent increase in plasma concentra-
tions of total S-thiolated proteins. In particular, we observed a little
increase in S-homocysteinylated proteins as well as a large increase
in S-cysteinylated proteins during ageing in healthy elderly individu-
als. The present results suggest that protection from oxidative dam-
age by plasma thiol redox buffer becomes less efficient with age; this
concerns not only decrease in plasma GSH [19, 28, 32] and increase
in total Cys and total Hcy [19], but also cysteinylation and homocys-
teinylation of plasma proteins.
Materials and methods
Materials
Monobromobimane (mBrB) was obtained from Calbiochem (La Jolla, CA,
USA). Acivicin, 5,5-dithiobis(2-nitrobenzoic acid) (DTNB), N-ethyl-
maleimide (NEM) and all the other reagents used in this study were of
analytical grade from Sigma-Aldrich (Milan, Italy). HPLC Spherisorb C18
column was purchased from Varian, Inc. (Palo Alto, CA, USA). HPLC sep-
aration was performed with an Agilent series 1100 HPLC equipped with
fluorescence detector. Spectrophotometric analyses were performed with
a Jasco V/530 instrument (Jasco Corporation, Tokyo, Japan).
Study participants
The study participants included 63 healthy individuals (38 females, 25
males) aged 20–93 years. Each participant declared not to have taken any
medicine in the last 7 days, and was screened for diagnosed diseases.
Individuals with diabetes or age-related cardiovascular, renal, pulmonary,
hepatic or ocular disease were excluded, and none of them had any abnor-
mality on physical examination nor in routine laboratory blood tests (serum
glutamic oxaloacetic transaminase [SGOT], serum glutamic piruvate
transaminase [SGPT], -glutamyltransferase [-GT], uraemia, creatinine-
mia, erythrocytes sedimentation rate, blood cell number, platelet number,
mean cellular volume, haematocrit, haemoglobin concentration, plasma
protein concentration, albumin concentration). In particular, none of the
individuals had any alterations in renal function (evaluated by the serum lev-
els of creatinine and urea levels) nor in hepatic function (evaluated by activ-
ity of -GT and transaminases). Furthermore, the selection excluded not
only individuals with acute infections or chronic diseases, but also excluded
healthy individuals undergoing supplementation with antioxidant sub-
stances. The individuals were divided into four age groups (Table 1).
All human experimentation was conducted in conformance with the
‘Principles for Research Involving Animals and Human Beings’ and
approved by the Local Ethical Committee of the University of Siena.
Informed consent was obtained from all the individuals after the purpose
and nature of the study had been explained.
Plasma collection and protein analysis
Blood samples were drawn in the morning after 10–12 hrs of starving from
the antecubital vein, collected in plastic tubes containing K3EDTA, acivicin
(50 g/ml) and either mBrB or NEM to alkylate free sulphydryls. Samples
were centrifuged at 10,000  g for 20 sec., at 4°C, for plasma separation;
this rapid centrifugation was applied in order to avoid, as much as possi-
ble, the efflux of mBrB-GSH conjugate from red blood cells that could arte-
factually increase the measured levels of plasmatic GSH [35]. After plasma
separation, S-thiolated proteins (i.e. the sum of S-homocysteinylated, S-
cysteinylglycinylated, S-glutathionylated and S-cysteinylated proteins),
total protein thiols (i.e. the sum of PSH  S-thiolated proteins; tPS), as
well as CysSH, (CysS)2, HcySH and (HcyS)2, were measured by HPLC with
fluorescence determination of the thiol-mBrB conjugate as previously
reported [36]. The relative amounts of S-homocysteinylated (HcySSP), S-
cysteinylglycinylated (CysGlySSP), S-glutathionylated (GSSP) and S-cys-
teinylated proteins (CysSSP) were calculated to the total amount of protein
cysteinyl thiols (tPS, i.e. PSH  S-thiolated proteins). A summary of the
procedures followed for accurate thiol/disulphide determination in human
plasma is reported in Fig. 1.
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Age groups No. of individuals Mean age Females Males
20–40 years 18 32.3 10 8
41–60 years 18 52.1 11 7
61–80 years 16 67.5 9 7
81–93 years 11 84.3 8 3
Table 1 Characteristics of study groups
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For determination of plasma levels of PSH, aliquots of blood samples
were collected in evacuated plastic tubes containing only K3EDTA and
acivicin (50 g/ml) and then immediately centrifuged at 10,000  g for 20
sec., at 4°C; plasma was then stored at –80°C until the analyses were car-
ried out. PSH determination was performed by spectrophotometry with
DTNB as a titrating agent [37].
Statistical analysis
For each age group, data are presented as the mean  S.D. Statistical
analysis among different age groups was performed by applying the one-
way ANOVA test and the Bonferroni’s test as multiple comparison method for
all pairwise. Linear regression was performed by applying the Pearson
product moment correlation test.
Results
Human red blood cells contain approximately 500 times higher
GSH concentration than plasma [26] so that minor haemolysis can
result in erroneously high plasma GSH values. Furthermore, thiols
can be lost by oxidation, which occurs with a half time of about 5
min. in plasma at room temperature [38]. Here, we have used a
procedure that we have optimized to collect blood with minimal
haemolysis, to prevent thiol oxidation and degradation during
sample processing and to provide a specific and sensitive meas-
ure of plasma thiols [19, 35, 36, 39].
In all measured plasma samples, independently of age, mean
values of PSH and S-thiolated proteins (i.e. S-cysteinylglycinylated
 S-glutathionylated  S-homocysteinylated  S-cysteinylated
proteins = RSSP) were 417.10  29.23 M and 182.9  29.30 M,
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Fig. 1 Schematic representation of the main analytical steps making the procedures we adopted for accurate thiol/disulphide determination in human
plasma. mBrB: monobromobimane; NEM: N-ethylmaleimide; DTT: dithiothreitol; LMW: low molecular weight and RSSP: protein/thiol mixed disulphides.
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respectively. On the basis of the total concentration for each low
molecular mass thiol species, i.e. the concentration of reduced
thiol  low-molecular-mass (symmetrical or unmixed) disul-
phides  S-thiolated proteins (i.e. protein/thiol mixed disulphides,
RSSP), in all measured plasma samples, independently of age,
tCys is present at the highest concentration (~237 M), with tCys
> tCysGly > tHcy > tGSH (Table 2). These results are in agreement
with other reports [19, 20, 40]. In this context, it is worth noting
that reported concentrations of low-molecular-mass disulphides
presented in Table 2 and throughout the manuscript are thiols
measured after reduction of disulphides (Fig. 1); thus, what
reported, for example, as GSSG is actually the sum of GSSG and
asymmetrical disulphides, i.e. CysSSG, HcySSG and CysGlySSG.
Hence, values reported by some authors, who discriminate
between GSSG and asymmetrical disulphides [29], may be lower.
Figure 2 shows micromolar plasma concentrations of total pro-
tein thiols (tPS = PSH  RSSP) for each age group. The distribu-
tion of the total protein thiol levels during ageing ranged from
about 589 to 618 M. There was neither significant age-related
tendency within this range nor significant difference between
males and females (not shown). Differently, results illustrated in
Fig. 3 show age-dependent diminution in plasma concentration of
PSH (Fig. 3A) as well as age-dependent increase in plasma con-
centrations of S-thiolated proteins (Fig. 3B). PSH declined with
age from about 449 to 397 M (–12%) (Fig. 3A), whereas the
level of S-thiolated proteins increased with age from about 163 to
221 M (35%) (Fig. 3B and C). Results illustrated in Fig. 3D
show age-dependent decrease in the plasma PSH/RSSP ratio from
about 2.7 to 1.8, most, if not all, of decrease becoming evident
over 60 years.
Measurements of S-cysteinylglycinylated and S-glutathiony-
lated proteins, as the relative amount of S-thiolated proteins to
total protein thiols and as a function of age, are illustrated in Fig.
4A and B, respectively. These S-thiolated proteins do not change
significantly in correlation with age.
Measurements of S-homocysteinylated and S-cysteinylated
proteins, as the relative amount of S-thiolated proteins to total
protein thiols and as a function of age, are illustrated in Fig. 4C and
D, respectively. An apparent, age-related minute increase (about
1%) was measured for S-homocysteinylated proteins, but varia-
tion of data also increased with age (Fig. 4C); however, the pres-
ence of S-homocysteinylated proteins, compared with that occur-
ring in the youngest individuals (first group of age), increased by
25% and 75%, respectively, in the individuals aged 61–80 years
and more than 80 years of age (Fig. 4C). Differently, a positive cor-
relation was determined between S-cysteinylated proteins and the
ageing process: results illustrated in Fig. 4D show a clear age-
dependent increase, ~8%, in plasma concentrations of S-cysteiny-
lated proteins. In comparison with the group of the youngest indi-
viduals, the percentage increase in S-homocysteinylated proteins
was about 26% and 35%, respectively, in the third and fourth
group of age. Notwithstanding there is evidence for an association
between S-cysteinylated proteins and age, there is also consider-
able variation among individuals of the same age group. However,
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Thiols Plasma levels (M)
GSH 2.23  0.78
GSSG 1.23  0.44 
GSSP 2.31  1.18 
Total GSH 5.79  1.80
HcySH 0.23  0.14
(HcyS)2 1.71  1.16 
HcySSP 9.33  3.57 
Total Hcy 11.25  4.44
CysGlySH 2.04  0.74
(CysGlyS)2 5.69  1.48 
CysGlySSP 11.96  2.96 
Total CysGly 19.74  3.93
CysSH 9.96  1.29
(CysS)2 67.74  13.59 
CysSSP 156.82  28.44 
Total Cys 237.11  36.61
Table 2 Plasma thiol levels in healthy individuals, independently of age 
Data are presented as the mean  S.D.
Fig. 2 Plasma levels of total protein thiols (tPS = reduced protein sul-
phydryl groups  S-thiolated proteins) for each age group. Data are
means  S.D.
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the data reported in Fig. 4C and D clearly show that, until approx-
imately 60 years of age, there is no significant association
between S-homocysteinylated and S-cysteinylated proteins and
age, whereas the ratio of S-homocysteinylated and S-cysteinylated
proteins to total protein thiols increase with age over 60 years.
The CysSH/(CysS)2 redox couple quantitatively represents the
largest pool of low-molecular-weight thiols and disulphides in
plasma [41], and the mean value of plasma CysSH/(CysS)2 pool in
human beings shows a significant oxidative shift between the third
and the ninth decade of life [6, 42]. Results illustrated in Fig. 5A
show that the plasma HcySH/(HcyS)2 ratio changes significantly
during the whole age range. Differently, we measured only a slight
age-dependent decrease (note the different scale range on 
the y-axis between Fig. 5A and B) in the plasma CysSH/(CysS)2
ratio (Fig. 5B).
Discussion
Major differences between cellular and extracellular compartments
exist both in terms of the concentrations of sulphydryl/disulphide sys-
tems and their relative redox states [41, 43]. Within cells, the major
low-molecular-weight sulphydryl/disulphide pool, GSH/GSSG, is
principally in the reduced form. Differently, the CysSH/(CysS)2 pool,
mainly in the disulphide form, quantitatively represents the largest
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Fig. 3 Plasma levels of reduced protein sulphydryl groups (PSH) (A) and S-thiolated proteins (RSSP) (B, C) for each age group. (D): Shows the age-
dependent decrease in the plasma reduced protein thiols/S-thiolated proteins (PSH/RSSP) ratio for each age group. Data are means  S.D. Statistical
significance (one-way ANOVA, P < 0.05): (A): 21–40 versus 61–80 and versus 81–93; 41–60 versus 81–93; (B): 21–40 and 41–60 versus 81–93. (C):
21–40 versus 61–80 and 81–93; 41–60 versus 61–80 and 81–93.
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pool of low-molecular-weight thiols and disulphides in plasma and
the extracellular compartment on the whole. Therefore, intracellular
proteins may be prevalently S-glutathionylated, whereas extracellular
proteins may be predominantly S-cysteinylated. For example,
although the small fraction of S-thiolated haemoglobin in red blood
cells is S-glutathionylated [44–47], plasma proteins such as albumin
are mainly S-cysteinylated [13, 26, 48].
In human plasma, concentration of PSHs is mostly due to cys-
teinyl residues of albumin, which reaches concentrations of more
than 500 M. As for the low-molecular-mass thiols, plasma con-
centration of GSH is generally in the range of 2–4 M [19, 20, 26],
CysSH is in the range of 8–10 M and that of (CysS)2 is higher
than 40 M [29]. Although representing only a minor component
as compared with protein cysteinyl thiols and free CysSH, GSH is
the most extensively studied extracellular thiol/disulphide compo-
nent in the human plasma during ageing [28, 32].
The present study shows no significant changes in the plasma
concentrations of total protein thiols (PSH  RSSP) for each age
group (Fig. 2). On the other hand, the age-related decrease in the
plasma level of PSHs is accompanied by a significant increase in the
concentration of S-thiolated proteins (Fig. 3). These data suggest
that there is some increase in oxidative events targeting protein thi-
ols throughout adult life, the phenomenon becoming clearly mani-
fest as from 60–70 years. The pools of S-thiolated proteins differ in
their relationships with age. There are scarce or no differences in the
relative amount (as compared to total plasma protein thiols) of 
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Fig. 4 Plasma levels of S-cysteinylglycinylated (CysGlySSP) (A), S-glutathionylated (GSSP) (B), S-homocysteinylated (HcySSP) (C), and S-cysteiny-
lated (CysSSP) and (D) proteins for each age group. All values are expressed as the percentage to total plasma protein thiols. Data are means  S.D.
Statistical significance (one-way ANOVA, P < 0.05): (C): 21–40 versus 81–93; 41–60 versus 61–80 and 81–93; 61–80 versus 81–93; (D): 21–40 versus
61–80 and 81–93; 41–60 versus 61–80 and 81–93.
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S-cysteinylglycinylated and S-glutathionylated proteins between
younger and older age groups of healthy individuals (Fig. 4A and B).
On the contrary, S-homocysteinylated and S-cysteinylated proteins
increase with age in healthy individuals (Fig. 4C and D). The age-
related homocysteinylation is accompanied by a significative
decrease in the plasma HcySH/(HcyS)2 ratio (Fig. 5A). In agreement
with other reports [6, 42], our results suggest that the age-related
cysteinylation is accompanied by a decrease in the plasma
CysSH/(CysS)2 pool in healthy human beings (Fig. 5B).
The most abundant reduced sulphydryl group in plasma is that
of human serum albumin (HSA), given its high concentrations.
The single free cysteinyl thiol of HSA, Cys34, accounts for ~80%
of reduced thiols in human plasma and is an important scavenger
of reactive oxygen and nitrogen species (ROS/RNS) in the vascu-
lar compartment, thus resulting to be a quantitatively important
redox buffer of blood [49–51]. Although albumin circulates mostly
(~70%) in the reduced state, an important fraction (~25%) of HSA
circulates as mixed disulphides with low-molecular-mass thiols,
mainly CysSH, likely via a stable sulphenic acid intermediate,
whereas a small fraction (~5%) is oxidized to higher, irreversible
oxidation states (i.e. sulphinic and/or sulphonic acids) [50–52].
This balance between reduced and oxidized forms of HSA can shift
in pathological states, and during ageing [51, 52]. Thus, decrease
in plasma PSHs, as seen in aged groups (Fig. 3A), has important
physiological implications. Reduced PSHs are important scav-
enger of ROS/RNS, thus homocysteinylation and cysteinylation of
plasma protein sulphydryls that occur in healthy elderly individu-
als over the age of 60 years (Fig. 4C and D) could contribute to the
decrease in the antioxidant capacity of plasma PSH. This involves
an increased risk of irreversible oxidation (i.e. further oxidation to
sulphinic and sulphonic acids) of protein thiols, which, because of
the emerging data suggesting an important role for the extracellu-
lar thiol/disulphide redox environment in inducing and/or affecting
intracellular signals that activate intracellular redox-sensitive path-
ways, such as cellular proliferation and matrix expression [41, 53,
54], may be critically important on signal transduction and tran-
scription events that utilize proteins containing sulphydryl groups
in reactive sites. Thus, the associated risk of adverse effects during
ageing may increase (Fig. 6).
Protein-bound HcySH accounts for 70% to 80% of plasma total
HcySH in healthy individuals [55, 56]. Homocysteinylation of
accessible CysSH residues in different cellular and plasma proteins
could alter their structure or function or both [57]. In vitro studies
have shown that homocysteinylation of the Cys9 residue of annexin
II, the endothelial cell surface docking protein for tissue plasmino-
gen activator, inhibits binding [58]. HcySH also binds the 
fibrin binding domain of plasma fibronectin, inhibiting its ability to
bind fibrin [59], as well as factor Va, making it resistant to inacti-
vation by activated protein C [60]. Furthermore, the amyloidogenic
protein transthyretin (pre-albumin) undergoes S-homocysteinyla-
tion at its single CysSH residue both in vitro and in vivo [61] and
homocysteinylation of LDL induces an increase in oxidative dam-
age and a decreased viability on human endothelial cells [62].
Intriguing, recent findings provide the first evidence of S-homocys-
teinylation of intracellular metallothionein, a ubiquitous intracellu-
lar zinc-chaperone and superoxide anion radical scavenger, which
results in loss of protein function, thus suggesting a novel mecha-
nism for disruption of intracellular zinc and redox homeostasis
[63]. These studies thus provide novel evidence as to how HcySH
may affect multiple cellular stress pathways [63].
Taken together, these studies suggest a possible link between
increased oxidative stress, decrease in plasma GSH and PSH [19, 28,
32], increase in S-thiolated proteins and ageing, thus suggesting that
antioxidant supplementation might be beneficial during ageing. On
the other hand, a few clinical investigations have shown that CysSH
supplementation exerts positive effects on certain functional and 
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Fig. 5 Effect of age on the homocysteine/homocystine, HcySH/(HcyS)2, (A) and the cysteine/cystine, CysSH/(CysS)2, (B) redox couple in healthy indi-
viduals. Data are means  S.D.
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biochemical parameters, which become typically compromised in
the course of ageing [64], supporting the hypothesis that oxidative
changes may contribute to the ageing process.
In conclusion, several lines of evidence indicate that oxidative
stress increases with age. Plasma redox values are dynamic indi-
cators of the systemic balance between oxidative and antioxidant
processes [6, 19, 41, 43]. The cross-talk among the various thiol
pools in plasma (redox thiol status) has been proposed to be an
element of the extracellular antioxidant defence system [6, 41,
65]. In this study, we show significant age-related changes of
important biomarkers of oxidative stress in human plasma of
healthy individuals. The increasing oxidative stress during ageing
is accompanied by a decrease in reduced protein sulphydryls, and
increase in S-homocysteinylated and S-cysteinylated proteins.
This finding does not only underline the ‘free radical hypothesis’
of ageing, but is also important for the evaluation of further clinical
studies with regard to basic (normal) values and with regard to the
usage of age matched healthy control groups. In principle, analy-
ses of reduced protein sulphydryls, S-homocysteinylated and S-
cysteinylated protein levels in human plasma can be used to
assess efficacy of intervention strategies against oxidative stress
prior to or early after onset of clinical symptoms in ageing and
age-related diseases.
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Fig. 6 Mean plasma PSH redox state becomes progressively oxidized with age after 60 years. Measurements of homocysteinylated and cysteinylated
plasma proteins in healthy individuals show that little variation occurs among younger individuals but, after about 60 years, plasma reduced protein sul-
phydryl groups become progressively S-thiolated with age, contributing to the decrease in the antioxidant capacity of plasma. Thus, the associated risk
of adverse effects during ageing may increase. In principle, S-thiolation in plasma protein thiols is reversible. Thus, if oxidative stress contributes to
oxidant-mediated changes of ageing and age-related diseases, nutritional modulation or therapeutic interventions might provide a potentially useful
strategy to restore redox state of human plasma.
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